Mark McCoy has over 25 years of experience in US and global pharmaceutical marketing and specializes in market access communications. His extensive experience includes developing and communicating powerful value propositions for prelaunch and launch brands in a broad range of therapeutic categories.

Earlene Biggs has over 20 years of experience delivering insights and strategies optimizing access and stakeholder engagement for pharmaceutical and biotech companies across the product lifecycle. In the past 5 years she has led her teams to successfully deliver 200+ research and analytics engagements with ICON clients.

Bruce Capobianco has supported business technology for over 20 years. He is a thought partner and trusted business advisor to clinical and commercial businesses by contributing to innovative and efficient study designs through robust evidence generation. Bruce is an evangelist in developing and driving adoption to AI to accelerate research.

Tanja Obradovic's experience includes 20+ years in clinical research as well as medical strategy leadership of oncology immunotherapy drug treatment value and reimbursement policy including packages for major private and public insurers and regulatory bodies such as CMS and NICE.

Ki Park leads a team of principal SMEs with expertise in advanced analytics in the areas of payer, patient, promotional effectiveness, and commercial strategy. His 15 years at Symphony Health has focused on healthcare claims informatics specializing in payer and patient analytics.

Nancy Risebrough is a Senior Principal within Global Health Economics and Outcomes Research at ICON. She has more than 20 years of experience working in decision analytic-modeling, health technology assessment (HTA), burden of illness studies, and reimbursement strategy and HTA submissions. Areas of therapeutic expertise include oncology, COPD, asthma, diabetes, and blood disorders.